About 6.2 million Americans suffer from heart failure, an incurable disease with a staggering mortality rate – some 40 percent of patients die within five years of diagnosis.
About 6.2 million Americans suffer from heart failure, an incurable disease with a staggering mortality rate – some 40 percent of patients die within five years of diagnosis. Heart failure is one form of heart disease, for which new therapies are desperately needed.
Now, in new work, scientists at the Lewis Katz School of Medicine (LKSOM) at Temple University identify a path to a promising novel therapeutic strategy, taking aim at a molecule in the heart known as G protein-coupled receptor kinase 5 (GRK5). In a study published online in the journal Cardiovascular Research, the scientists show in mice that reducing GRK5 levels can significantly improve survival following heart attack.
Read more at: Temple University Health Systems
Photo Credit: PublicDomainPictures via Pixabay
